Medicine details

ImageAxosin IV 250 mg
NameAxosin IV 250 mg
DosageIV Injection
Generic NameCeftriaxone
Classes Antiinfective Agent
Antibiotic
Cephalosporine
Diseases Bone Infection
Bronchitis
Gonorrhea
Infectious Disease
Meningitis
Otitis
Pelvic Inflammatory Disease (PID)
Pneumonia
Sinusitis
Tonsillitis
Urethritis
CompanyIbn Sina Pharmaceutical Ind. Ltd.

Drug Package Details

Strength250 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack1
Price per pack89.65
Cost per pack78.89
Package unit250 mg combipack
Price per unit89.65
Cost per unit78.89
Discount0
Coupon
Remarks

Ceftriaxone

Ceftriaxone is a broad-spectrum parenteral cephalosporin antibiotic of the third generation. It has strong bactericidal properties against both Gram-positive and Gram-negative bacteria.

Ceftriaxone is indicated for the following infections causes by susceptible strains-

  • Lower respiratory tract infections
  • Acute Bacterial Otitis Media
  • Skin and skin structure infections
  • Urinary tract infections
  • Gonorrhea
  • Bacterial Septicemia
  • Bone and joint infections
  • Meningitis
  • Prevention of postoperative infections
  • Perioperative prophylaxis of infections associated with surgery
  • Lyme disease

Ceftriaxone is only available as intravenous and intramuscular injection. The usual dose for adults is 1-2 gm per day.

The common side effects of ceftriaxone are-

  • Nausea
  • Vomiting
  • Diarrhea
  • Eosinophilia
  • Thrombocytosis

 

  • Hypersensitivity reaction & Anaphylactic shock may occur, in such cases immediate clinical attention is required.
  • Severe cases of hemolytic anemia, including fatalities in adults and children, have been reported.
  • Interaction with Calcium-containing Products: Precipitation can occur. Do not administer simultaneously with calcium-containing IV solutions.
  • Patients with both hepatic and renal impairment should not received more than 2 grams of ceftriaxone per day.

Contraindication

Contraindicated in patients hypersensitive to any beta lactam antibiotics such as-

Ceftriaxone is contraindicated in newborns under 28 days.